PS1160 PATTERNS OF DUVELISIB-INDUCED LYMPHOCYTOSIS IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA INCLUDING THOSE WITH HIGH-RISK FACTORS TREATED IN THE DUO TRIAL

Authors :: Amanda F. Cashen
J. Pachter
J. Brown
Stephanie Lustgarten
Ian W. Flinn
Nicholas Chiorazzi
J. Barrientos
M. Davids
S. Hidy
S.-S. Chen
D. Weaver
Source :: HemaSphere. 3:526-527
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Oncology
medicine.medical_specialty
Lymphocytosis
business.industry
Chronic lymphocytic leukemia
Hematology
High risk factors
medicine.disease
Duvelisib
chemistry.chemical_compound
Leukemia
chemistry
Internal medicine
Relapsed refractory
medicine
In patient
medicine.symptom
business

Tools